<DOC>
	<DOCNO>NCT02029833</DOCNO>
	<brief_summary>The objective study examine health benefit dietary canola oil body composition , specifically android fat , weight management . COMIT II also include analysis FAEs elucidate mechanism canola oil may modify body composition . Measurement endothelial function , inflammatory , adiposity , insulin sensitivity biomarkers do determine positive health impact change body composition achieve canola oil consumption .</brief_summary>
	<brief_title>Canola Oil Multi-Centre Intervention Trial II</brief_title>
	<detailed_description>The propose multi-center clinical trial would engage collaborative team successfully operationalized COMIT I , namely , Richardson Centre Functional Foods Nutraceuticals ( RCFFN ) University Manitoba ( Winnipeg , Manitoba , Canada ) , L'Institut Des Nutraceutiques et des Aliments Fonctionnels ( INAF ) Laval University ( Quebec City , Quebec , Canada ) , Department Nutritional Sciences The Pennsylvania State University ( University Park , Pennsylvania , USA ) , Risk Factor Modification Centre St. Michael 's Hospital ( Toronto , Ontario , Canada ) . St. Boniface Hospital Research ( Winnipeg , Manitoba , Canada ) additional clinical trial site . The propose COMIT II research program proceed double blind , randomize crossover study consist three treatment phase six week , separate 6-week washout period . Participants consume fix composition precisely control basal , weight-maintaining diet ( 35 % energy fat , 50 % carbohydrate 15 % protein ) supplement follow treatment oil : ( ) regular canola oil , ( b ) high stability/ high oleic canola oil ( c ) typical `` Western diet '' fat intake control treatment comprise largely saturated fat substantial level omega-6 linoleic acid , common current North American intake . Treatment oil isocalorically incorporate fruit smoothy make milk consume breakfast supper . The clinical segment COMIT II expect complete mid end second year , sample analysis complete end year three .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Waist circumference ≥94 cm men ≥80 cm woman Participants must meet least one follow secondary inclusion criterion : Fasting blood glucose ≥ 5.6 mmol/L Triglycerides ( TG ) ≥1.7 mmol/L HDL cholesterol ( HDL ) &lt; 1 mmol/L ( male ) &lt; 1.3 mmol/L ( female ) Blood pressure ≥130 mmHg ( systolic ) and/or ≥85 mmHg ( diastolic ) . Kidney , liver disease , unstable thyroid disease Diabetes mellitus Smokers Those consume &gt; 1 alcoholic beverage day woman &gt; 2 men . Any participant taking medication know affect lipid metabolism endothelial function</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>